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Abstract
Objective – To describe clinical data of hospitalized adult equids and foals with tetanus.
Design – Multicenter retrospective study (2000–2014).
Setting – Twenty Western, Northern, and Central European university teaching hospitals and private referral
centers.
Animals – One hundred fifty-five adult equids (>6 months) and 21 foals (<6 months) with tetanus.
Interventions – None.
Measurements and Main Results – Information on geographic, annual and seasonal data, demographic- and
management-related data, clinical history, clinical examination and blood analysis on admission, complications,
treatments, and outcomes were described and statistically compared between adults and foals. The described
cases were often young horses. In 4 adult horses, tetanus developed despite appropriate vaccination and in
2 foals despite preventive tetanus antitoxin administration at birth. Castration, hoof abscesses, and wounds
were the most common entry sites for adults; umbilical cord infections and wounds for foals. Stiffness was
the commonest observed initial clinical sign. Blood analyses frequently revealed an inflammatory response,
hemoconcentration, muscle damage, azotemia, negative energy balance, liver damage, and electrolyte and acid
base disturbances. Common complications or clinical signs developing during hospitalization included dys-
phagia, dyspnea, recumbency, hyperthermia, seizures, hyperlipemia, gastrointestinal impactions, dysuria, and
laryngeal spasms. Cases were supported with wound debridement, antimicrobial treatment, tetanus antitoxin,
muscle spasm and seizure control, analgesia, anti-inflammatory drugs, fluid therapy, and nutritional support.
Mortality rates were 68.4% in adult horses and 66.7% in foals. Foals differed from adult horses with respect
to months of occurrence, signalment, management-related data, potential causative events, clinical signs on
admission, blood analysis, complications, and severity grades.
Conclusions – This is the first study that rigorously describes a large population of equids affected by tetanus.
The informationprovided is potentially useful to clinicians for early recognition and casemanagement of tetanus
in adult horses and foals. Tetanus affects multiple organ systems, requiring broad supportive and intensive care.
Neonatal and adult tetanus in the horse should be considered as distinct syndromes, as in human medicine.
(J Vet Emerg Crit Care 2017; (): 1–12) doi: 10.1111/vec.12668
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Tetanus is a highly fatal disease in horses, with de-
scriptions of the disease dating back to the time of
Hippocrates.1,2 The responsible bacterium, Clostridium
tetani, and its toxins were isolated and characterized
by the end of the 19th century. Subsequently success-
ful passive immunization of horses against tetanus was
introduced,3,4 leading to a dramatic decrease in the in-
cidence of this disease. Despite the fact that currently
tetanus only occurs sporadically,5 equine clinicians are
still likely to encounter at least one case during their
careers.5,6 The significantly decreased exposure rate of
veterinarians to tetanus emphasizes the need for detailed
descriptions of recent cases to help clinicians with early
disease recognition and up-to-date patientmanagement,
particularly in the face of the currently reported subop-
timal vaccination rates in Europe.7,8 An up-to-date de-
scriptive overview of tetanus in the horse including de-
tails of the history and clinical progression of the disease
is currently lacking. Most of the available literature gen-
erally only provides data on small numbers of cases or
limited variables. Moreover, previous reports describe
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cases managed before 2000,5,6,9–11 or do not reflect the
current approach in equine medicine in Europe.6,12,13
Disease progression, complication rates, and outcomes
of recent cases may be different from earlier reports due
to improvements in treatments, especially in developed
countries. Furthermore, neonatal tetanus is considered a
separate entity to adult tetanus in human medicine.14 It
is highly likely that equine neonates also have a differ-
ent disease history and course compared to adults, yet
none of the currently available studies describe the his-
tory, clinical features, or outcomes of tetanus in multiple
foals.
The aims of this study were to describe in detail the
history, clinical presentation, and progression of adult
horses and foals affectedby tetanus thatwere admitted to
equine referral hospitals throughout Western, Northern,




and the European College of Equine Internal Medicine,
potential scientific collaborators were identified. The fol-
lowing criteria for collaborators were used: (1) located
in Western, Northern, or Central Europe, (2) working
in an academic equine referral center, or a large, pri-
vate referral center with interest in scientific research, (3)
working in a referral clinic where at least 1 equine inter-
nal medicine specialist (Diplomate ECEIM or ACVIM) is
employed. At least 1 academic clinic was searched and
contacted for every country. All collaborators who had
diagnosed tetanus cases since the year 2000, and who
agreed to collaborate in the study, received a case defi-
nition and a detailed, standardized data spreadsheet for
specific variables to be retrospectively retrieved from the
medical records. Subsequently, all data were collected,
checked, and analyzed by the first author (G. vanGalen).
Case definition
The following case inclusion criteria were used for this
study: (1) cases with a clinical diagnosis of tetanus, (2)
admitted to the referral hospital of a collaborator, (3) ad-
mitted between the years 2000 to 2014. Since no defini-
tive diagnostic tests are available for tetanus, a clinical
diagnosis of tetanus was based on the presence of the
most typical and consistent clinical signs reported in the
published literature (eg, stiffness, trismus, or protrusion
of the third eyelid), and the absence of clinical signs,
laboratory results and, where applicable, postmortem
findings that indicated any other disease that could ex-
plain the clinical presentation.16 Cases with the follow-
ing findings were excluded from the study: (1) serum
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biochemical evidence of significant rhabdomyolysis (ie,
creatine kinase activity of >10,000 U/L, or the presence
of myoglobinuria), (2) hypocalcemia (ionized calcium <
1 mmol/L [2 mEq/L], total calcium < 2 mmol/L
[4 mEq/L]), (3) signs and laboratory results suggestive
of hepatic encephalopathy or significant liver damage
(gamma-glutamyl transferase activity > 150 U/L), and
(4) signs or result of complementary examinations sug-
gestive of other neurological conditions.
Based on resemblance of the clinical parameters in
foals older than 6 months and adults, and the fact that
all foals should theoretically have received a first vacci-
nation at this age, cases were divided into >6 months
old (adults) and <6 months old (foals).
Retrieved data from reported cases and definitions
Detailed information about cases was retrieved retro-
spectively from the files with owner informed consent.
For a minority of the cases no consent could be obtained
because of absence of standard consent contracts on ad-
mission and unsuccessful attempts to reach the owner.
Geographic, annual, and seasonal data
Thedate of the first recognized clinical signwas recorded
aswell as the referral clinic and the country of the referral
clinic.
Demographic and management related data
Breed, sex, age at the time of onset of disease, body con-
dition (eg, normal, poor or obese), and exercise activity
(eg, in training or in competition) were recorded. Cases
were allocated into the following categories relating to
tetanus vaccination: never vaccinated or correctly vac-
cinated according to the guidelines from the American
Association of Equine Practitioners of a primary double
vaccination with 4–6 weeks interval between doses and
followed by a yearly booster.17 In addition, the reason
for not vaccinating was recorded. For foals it was noted
if they had received tetanus antitoxin (TAT) after birth.
It was noted whether cases were microchipped and de-
wormed.
Clinical history
The first clinical sign noted by the owner, any signifi-
cant history prior to the onset of disease, entry sites or
wounds, evidence of visible infection or necrosis at po-
tential entry sites or wounds, and whether preventive
TAT was administered following this event were noted.
Thedistance from thehomepremises to the referral clinic
was recorded in hours of travelling duration. The follow-
ing dates were noted: date of the preceding significant
event (if present; T1), date of development of the first
Table 1: Severity grades of tetanus for horses, adapted from At-
tygalle and Rodrigo, and Miranda-Filho et al2,29
Grade Criteria
Mild Mild-moderate trismus, general stiffness, no respiratory
problems, no spasms, little or no dysphagia
Moderate Moderate trismus, marked stiffness, mild-moderate
short spasms, moderate respiratory embarrassment,
mild dysphagia
Severe Severe trismus, generalized stiffness, reflex prolonged
spasms, respiratory embarrassment (respiratory rate
>60/min), apneic periods, severe dysphagia,
tachycardia (>60/min)
Very severe Similar criteria as the severe grading, plus violent
autonomic disturbances of cardiovascular system
(severe hypertension and tachycardia alternating with
hypotension and bradycardia)
clinical signs of tetanus (T2), date of the development of
the first spasm (T3), date of clinical diagnosis of tetanus
(T4), date of first treatment (excluding TAT; T5), date of
first therapeutic treatment with TAT (T6), date of referral
(T7), date of death (where appropriate; T8), date of start
of clinical improvement (where appropriate; T9), date of
complete clinical recovery (where appropriate; T10), and
date of discharge fromhospital (where appropriate; T11).
Using these dates, the following intervals (in days) were
calculated: incubation time (T1-T2), onset time (T2-T3),
diagnosis time (T2-T4), treatment delay (T2-T5), TAT de-
lay (T2-T6), hospitalization delay (T2-T7), disease length
for nonsurvivors (T2-T8), period after which recovery
starts (T2-T9), disease length for survivors (T2-T10), and
hospitalization length (T7-T11 or T7-T8).
Hospitalization
The results of blood analyses on admission or the
first sampling time following admission were recorded.
Complications or clinical signs that developed during
hospitalization were recorded. Treatments were noted
with specific emphasis on use of antimicrobials, TAT
(eg, dosage, frequency, and administration route), mus-
cle relaxants, analgesics, and fluid therapy and nutri-
tional support. Grades of severity of tetanus (Table 1), the
costs of the hospitalization, the final outcome (survivor
or nonsurvivor), and results of postmortem examination
were recorded.
Detailed data on outcome and prognostic factors are
described in Part 2 of this study.18
Statistical methods
Adult cases and foalswere compared by statistical analy-
sis: 2-sample t-test with unequal variances for numerical
C© Veterinary Emergency and Critical Care Society 2017, doi: 10.1111/vec.12668 3
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Table 2: Northern, Western, and Central European countries

















Cases were categorized by the reporting referral clinic, not by physical lo-
cation where they lived. A case could therefore be categorized as reported
by Belgium but patient could have resided in the north of France.
∗Absence of cases in the participating hospitals since the year 2000 or
cases that were too poorly reported for use in this study.
variables, andFisher’s exact test for categorical variables.
Significance was set at P < 0.05.
Results
In total, 185 cases were reported, of which 176 cases ful-
filled the inclusion criteria for this study. Of those 176
cases, 120were nonsurvivors and 56were survivors, giv-
ing a survival rate of 31.8% and amortality rate of 68.2%.
Of these 176 cases, 155 were adult equids and 21 were
foals younger than 6 months.
Geographic, annual, and seasonal distribution of cases
Cases were reported from 20 different referral clinics.
TheUniversities of Ghent and Liege in Belgium reported
most cases (71 and 20, respectively; Table 2). Annual dis-
tribution and seasonal distribution of the cases is illus-
trated in Figures 1 and 2, respectively. Peaks occurred in
the months of April and December for adults, whereas
cases in foals tended to occur in spring and summer.
Demographic- and management-related data
Cases had variable ages ranging from 6 days to 20 years,
but most were young (4 years or younger). The majority
of affected equids were saddle horses (ie, riding horses),
of normal body condition, and not microchipped. Most
were not being exercised. The adult and foal groups both
showed an equal sex distribution. Twomares were preg-
nant. Very little data could be obtained on deworming
history (response rate <25%). Most adults were never
vaccinated, yet 4 were appropriately vaccinated (they
were 1.5, 2.6, 4, and 13 years old at onset of disease).None
of the foals had been vaccinated, but 2 received TAT at
birth (they were 1 month and 6 days old at the onset of
disease; Table 3). Vaccination status of the dams was un-
known. Reasons given by the owners for not vaccinating
were: ignorance (lack of knowledge about tetanus or ap-
propriate vaccination regimen); postponeddue tohouse-
keeping/practical problems; advice from horse dealer;
the foal was too young, and the damwas not vaccinated;
purchased recently and no information on vaccination
status available; vaccination costs too high; no previous
problems with a nonvaccination strategy.
Clinical history
For one third of the adults and the foals, a specific
event was noted that potentially could have caused
tetanus. Castration, hoof abscesses, and wounds were
the most common events for adults, whereas in foals
preceding events were only umbilical cord infections or
wounds. Prophylactic administration of TAT following
these events was only undertaken in 10 adult cases and
not in any of the foals (Table 4).
Disease intervals were quite similar for both groups
(Table 5). Incubation times were variable with a mean
of 1 week. Onset time, diagnosis time, treatment delay,
TATdelay, andhospitalizationdelaywereusuallywithin
24 hours of the onset of disease.
Hospital admission
Stiffness was reported by the owner as the most com-
monly observed initial clinical sign. The clinical signs
recorded at admission to the hospitals are summarized
in Table 6. Not all cases showed all of the signs of the
study definition of tetanus (eg, stiffness, third eyelid pro-
trusion, trismus) on admission, but they had at least 1 of
the 3 signs on admission and developed the other signs
later in the course of the disease. Trismus was frequently
not present on the day of admission. Common clinical
signs identified early in the course of the disease in more
than 50% of adult horseswere: stiffness, third eyelid pro-
trusion, trismus, agitation, wide-based stance, extended
neck, elevated tail, dysphagia, anorexia, abnormal (de-
creased or absent) intestinal sounds, and abnormal (de-
creased or absent) defecation. In foals, common clinical
signs identified early in the course of the disease were
slightlydifferent and included: stiffness, third eyelidpro-
trusion, recumbency, muscle spasms, extended neck, ab-
normal (decreased or absent) defecation, and abnormal
(decreased or absent) urination. The majority of foals
and adults additionally hadnormalmucousmembranes,
normal rectal temperature, tachycardia, and tachypnea,
although congested mucous membranes, low or normal
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Figure 1: Annual distribution of adult horses and foals with tetanus. The year of disease of a case was based on the date of the first
clinical sign or, if that date was unknown, on the date of hospitalization.
heart rates, normal respiratory rates, hypothermia, and
hyperthermia also occurred regularly. Five horses were
reported to have arrhythmias on cardiac auscultation.
A small groupof horseswas euthanizedonor immedi-
ately after admission without initiation of treatment: 10
adults (of which 4 were euthanized for financial reasons;
the other 6 hadmoderate [1] and severe grading [5]) and
2 foals (none for financial reasons, but with severe [1]
and very severe grading [1]).
Hospitalization and outcome
The results of blood analyses most frequently revealed
evidence of an inflammatory response, hemoconcentra-
tion,muscle damage, azotemia, negative energy balance,
liver damage, electrolyte disturbances, and metabolic
and respiratory acid base disturbances (Table 7). In only
2 cases a bacterial culture was performed of the wound,
and in one of these C tetani was cultured.
Cases were treated with wound debridement (91% of
the cases with a wound), penicillin (75.8% intravenously
and 21.3% intramuscularly), metronidazole (8.3%), and
other antimicrobials with or without penicillin (45.2%).
Furthermore, 97.6% received therapeutic doses of TAT,
of which the majority was administered intravenously
(89.3%) with a total dose of 5,000–600,000 IU (mean
80,374 ± 69,070 IU) divided over 1–9 injections. A single
atlanto-occipital intrathecal TATadministrationwasper-
formed in 16 adults cases with a dosage of 8,000–58,000
IU (mean 35,173± 14,943 IU). One horse was reported to
collapse during intrathecal TAT administration. Twelve
of those 16 did not survive tetanus. Four adults, of which
2 survived, did not receive any TAT. Several drugs,
such as acepromazine (87%), diazepam (39.7%), mida-
zolam (2.1%), alpha2-adrenergic agonists (27.4%), glyc-
erol guaiacolate (16.4%), magnesium (3.4%), methocar-
bamol (2.7%), dantrolene (2.1%), and barbiturates (0.7%),
Figure 2: Seasonal distribution of adult horses and foals with tetanus. The month of disease of a case was based on the date of the first
clinical sign or, if that date was unknown, on the date of hospitalization.
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Table 3: Demographic- and management-related data of foals
and adult horses with tetanus
Adult horses (155) Foals (21)
Age (years) #
Mean ± SD 4.2 ± 3.8 0.2 ± 0.2
Median 3.0 0.10
Range 0.6–20.0 6 days–6
months
N 152 17
n N % n N %
Breed
Pony 20 152 13.2 6 21 28.6
Donkey 7 152 4.6 0 21 0.0
Draft horse 11 152 7.2 2 21 9.5
Saddle horse 114 152 75.0 13 21 61.9
Sex
Mare 89 154 57.8 10 21 47.6
Gelding 36 154 23.4 1 21 4.8 #
Stallion 29 154 18.8 10 21 47.6 #
Body condition
Normal 115 130 88.5 18 21 85.7
Poor 11 130 8.5 3 21 14.3
Obese 4 130 3.1 0 21 0.0
Exercise activity
In training 13 110 11.8 0 21 0.0
In competition 1 107 0.9 0 21 0.0
Tetanus immunization
Never vaccinated 72 109 66.1 18 20 90.0 #
Correctly vaccinated∗ 4 106 3.8 0 19 0.0
TAT after birth∗∗ - - - 2 16 12.5
Microchipped 29 103 28.2 0 19 0.0 #
N, number of horses with a response for this specific parameter; n, number
of horses with a positive response.
∗According to the guidelines from the American Association of Equine
Practitioners of a primary double vaccination with 4- to 6-week interval
between doses and followed by a yearly booster.17
∗∗Only recorded for foals.
#Variable statistically different between groups.
were used to control muscle spasms. Nonsteroidal anti-
inflammatory drugs (32.9%), morphine or morphine
derivatives (4.8%), a continuous rate infusion of lido-
caine (2.1%), and dimethyl sulphoxide (2.8%) were used
as analgesic or anti-inflammatory therapies. Despite the
fact that about half of the cases (58.5%)were able todrink,
intravenous (85.6%) or oral (21.9%) fluid therapies were
used frequently to provide cardiovascular support. Vol-
untary eating of normal or softened food was possible
for 27.0% and 39.4% of cases, respectively. Tube feeding,
intravenous administration of glucose, and parenteral
nutrition were utilized to provide nutritional support in
15.7%, 47.6%, and 1.4%, respectively. Most cases were
placed in a darkened (97.9%), padded (78.6%), and silent
(97.9%) stable to reduce stimuli-induced muscle spasms
and seizures, and in some cases a slingwas used (30.7%).
Complications or clinical signs that developed during
hospitalization and which reporting veterinarians were
specifically questioned about are shown in Table 8. Com-
monly dysphagia, dyspnea, recumbency, hyperthermia,
seizures, hyperlipemia, gastrointestinal impactions, dy-
suria, and laryngeal spasms were encountered dur-
ing hospitalization. In addition to the standardly ques-
tioned ones, the following complications or clinical signs
were reported: apnea (5), laminitis or increased digi-
tal pulses (4), pulmonary edema (3), opisthotonus (3),
inflammation at an intramuscular injection site (1), se-
vere head and neck edema (1), abortion (1), photopho-
bia (1), corneal ulcers (1), contracted carpi and fetlocks
(1 foal), cecal impaction with subsequent rupture (1).
For both age groups, cases were mainly categorized as
mild,moderate or severe, andvery severe caseswere rare
(Table 9).
Mortality rates were similar in both groups: 68.4%
(106/155) in adults and 66.7% (14/21) in foals. Only 12
nonsurvivors died after more than 7 days of the onset
of clinical disease; the remainder died within the first
week. Twenty-four adult cases and 4 foals underwent a
full postmortemexamination.Noneof themhadgross le-
sions that could explain the clinical syndrome. Addition-
ally, gastrointestinal parasites were found in 35% (7/20)
of the adult horses undergoing postmortem examina-
tion, 1 had a rupture of the femoral head ligament, and
6 had muscle lesions (eg, local myositis, fiber degenera-
tion, muscle tearing, hemorrhage).
The survival rates of the adults and foals were 31.6%
(49/155) and 33.3% (7/21), respectively. Initial signs
of clinical improvement were typically seen after >1
week after the onset of disease, with full recovery com-
monly occurring within 3 weeks. Nine adult horses and
1 foal were discharged before full recovery from tetanus
(Table 5). The average hospitalization timewas 9–10days
(Table 5) with an associated cost of € 902± 784 for adults
(n = 130) and € 835 ± 947 for foals (n = 18).
Statistical comparison between adult horses and foals
with tetanus
Variables more associated with adults compared to foals
included: gelding, microchipped, presence of a wound,
third eyelid protrusion, trismus, wide-based stance, el-
evated tail, dysphagia and normal urination on admis-
sion, and moderate disease grading. Variables more as-
sociatedwith foals compared to adults included: stallion,
never vaccinated, no event noted that could be at the ori-
gin of the disease, generalized seizures and recumbency
on admission, development of increased rectal temper-
atures during hospitalization, and very severe disease
grading. Moreover, foals had a significantly higher heart
rate, respiratory rate, rectal temperature, white blood
cell count, blood sodium, and ionized calcium concen-
tration on admission, but a significantly lower serum
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Table 4: Variables from the clinical history of adult horses and foals with tetanus
Adult horses (155) Foals (21)
n N % n N %
Event before tetanus development
No event noted 72 154 46.8 15 21 71.4% #
Castration 11 154 7.1 0 21 0.0%
Other surgery 3 154 1.9 0 21 0.0%
Hoof abscess 14 154 9.1 0 21 0.0%
Dental floating 1 154 0.6 0 21 0.0%
Retained placenta (mares) 0 154 0.0 – – –
Umbilical cord infection (foals) – – – 3 21 14.3%
Wound 59 154 38.3 3 21 14.3% #
Visual inspection wound
Infection 29 57 50.9 4 6 66.7%
Necrosis 10 51 19.6 0 5 0.0%
Preventive TAT in relation to event 10 74 13.5 0 6 0.0%
N, number of horses with a response for this specific parameter; n, number of horses with a positive response; TAT, tetanus antitoxin.
#Variable statistically different between groups.
total protein concentration, creatinine concentration, and
gamma-glutamyl transferase activity than adult cases
(Tables 3–9).
Discussion
To the best of the authors’ knowledge, this is the first
study that rigorously describes a large European pop-
ulation of horses affected by tetanus. This study pro-
vides clinicians with an evidence-based description of
the clinical disease, which is useful not only in regards
to recognizing and diagnosing the disease, but also with
treatment, prevention of complications, and prognosis.
In agreement with previous reports,5 stiffness was the
most consistently recognized early sign of the disease
in the present study. Protrusion of the third eyelid and
trismusdeveloped later in the course of thedisease, espe-
cially in foals, which potentially might complicate early
recognition of the disease since these signs have been
described as key features of tetanus.16
Analyzing the most common clinical signs, results
of blood analyses and complications associated with
tetanus, clinicians should recognize that the disease
affects multiple organ systems, requiring broad sup-
portive and often intensive care. Treatments should
focus on support of the respiratory and cardiovascular
systems, the gastrointestinal tract (including nutritional
support), the urinary system, and metabolic functions.
Moreover, traumatic complications as result of violent
contractions or seizures, such as fractures, muscle or
ligament trauma, decubital ulcers, and corneal ulcers,
can occur and clinicians should attempt to avoid these
with proper care of recumbent horses and control of
seizures and muscle spasms. A small number of horses
were graded as very severe with reference to autonomic
disturbances. This number is likely to be underreported
Table 5: Disease intervals of adult horses and foals with tetanus
Adult horses (155) Foals (21)
Mean ± SD M R N Mean ± SD M R N
Incubation time (days) 10.8 ± 7.3 8.0 1–43 49 6.0 6.0 6.0 1
Onset time (days) 0.5 ± 1.3 0.0 0.0–12 135 0.3 ± 0.8 0.0 0.0–3.0 21
Diagnosis time (days) 1.2 ± 2.5 0.5 0.0–19 144 0.9 ± 1.6 0.0 0.0–5.0 21
Treatment delay (days) 1.2 ± 2.6 0.5 0.0–19 140 0.8 ± 1.5 0.0 0.0–5.0 19
TAT delay (days) 1.2 ± 2.6 0.5 0.0–19 137 0.8 ± 1.5 0.0 0.0–5.0 19
Transport time (hours) 1.5 ± 1.0 1.0 0.5–7.5 77 1.2 ± 0.7 1.0 0.5–3.0 10
Hospitalization delay (days) 1.4 ± 2.8 0.5 0.0–19 143 1.1 ± 1.9 0.1 0.0–6.0 21
Disease length for NS (days) 4.2 ± 5.5 3.0 0.0–38 103 3.6 ± 4.2 2.0 0.0–16 14
Period after which recovery starts (days) 8.5 ± 5.3 8.0 2.0–21 38 8.7 ± 3.3 10.0 3.0–12 7
Disease length for S (days) 19.6 ± 6.7 20.5 5.0–33 34 21.0 ± 16.2 17.0 7.0–53 6
Hospitalization length (days) 8.9 ± 10.7 3.5 0.0–52 155 10.1 ± 13.5 3.7 0.0–56 21
SD, standard deviation; M, median; R, range; N, number of horses with a response for this specific parameter; NS, nonsurvivor; S, survivor; TAT, tetanus
antitoxin.
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Table 6: Clinical signs on admission of adult horses and foals with tetanus
Adult horses (155) Foals (21)
n N % n N %
Case definition signs
Stiffness 151 155 97.4 21 21 100
Third eyelid protrusion 139 150 92.7 15 21 71.4 #
Trismus 93 148 62.8 8 21 38.1 #
Mental status—consciousness
Normal 31 143 21.7 3 21 14.
Depressed 42 140 30.0 8 21 38.1
Generalized seizures 9 140 6.4 6 20 30.0 #
Agitated 75 138 54.3 7 20 35.0
Anxious 48 137 35.0 5 20 25.0
Other neurological signs
Recumbency 18 155 11.6 13 21 61.9 #
Involuntary muscle contractions/spasms 63 148 42.6 12 20 60.0
Wide-based stance 74 142 52.1 2 19 10.5 #
Retracted lips 37 123 30.1 2 20 10.0
Pulled down ears 44 129 34.1 3 18 16.7
Extended neck 81 136 59.6 11 20 55.0
Elevated tail 92 136 67.6 5 19 26.3 #
Dysphagia 81 138 58.7 4 18 22.2 #
Clinical examination
Heart rate (bpm) #




Respiratory rate (bpm) #




Rectal temperature (°C) #




Normal mucous membranes 87 133 65.4 12 18 66.7
Dyspnea 58 129 45.0 9 20 45.0
Normal intestinal sounds 41 93 44.1 6 10 60.0
Normal defecation 39 85 45.9 3 10 30.0
Anorexia 71 130 54.6 8 19 42.1
Signs of colic 18 145 12.4 0 21 0.0
Normal urination 53 62 85.5 4 8 50.0 #
Sweating 59 144 41.0 6 19 31.6
N, number of horses with a response for this specific parameter; n, number of horses with a positive response; bpm, beats/breaths per minute; #, variable
statistically different between groups.
since measurements of autonomic parameters (such as
blood pressure and continuous heart rate monitoring)
are rarely systematically undertaken in equinemedicine.
However, the relative bradycardia in some horses in this
study in the face of painfulmuscle cramps and the severe
tachycardia in others are suggestive of autonomic dys-
function. This phenomenon of autonomic disturbances
is well described in people2 and dogs19,20 suffering from
tetanus, but this is the first time it has been reported in
horses.
Despite the comparable survival rates compared to
previous reports in the published literature, some differ-
ences can be noted with regards to complications. In the
study fromMuylle with 108 cases, the only complication
described was aspiration pneumonia.11 This complica-
tion only developed in 2 adult horses and 2 foals in the
8 C© Veterinary Emergency and Critical Care Society 2017, doi: 10.1111/vec.12668

















































































































































































































































































































































































































































































































































































































































































































































































































































































C© Veterinary Emergency and Critical Care Society 2017, doi: 10.1111/vec.12668 9












































































































































































































































































































































































































































































































































10 C© Veterinary Emergency and Critical Care Society 2017, doi: 10.1111/vec.12668
Adult horses and foals with tetanus
Table 8: Complications and clinical signs that developed during hospitalization in adult horses and foals with tetanus
Adult horses (155) Foals (21)
N n % N n %
Dysphagia 97 136 71.3 9 19 47.4
Recumbency 77 143 53.8 13 19 68.4
Dyspnea 73 141 51.8 8 19 42.1
Increased rectal temperature (>38.5°C) 31 127 24.4 13 19 68.4 #
Seizures 28 142 19.7 6 19 31.6
Hyperlipemia 9 89 10.1 0 14 0.0
Gastrointestinal impaction 12 135 8.9 3 17 17.6
Weight loss 9 112 8.0 0 17 0.0
Dysuria 10 132 7.6 2 19 10.5
Laryngeal spasms and/or stridor 10 135 7.4 2 19 10.5
Decubital ulcers 8 141 5.7 0 19 0.0
Thrombophlebitis 7 143 4.9 1 19 5.3
Diarrhea 6 143 4.2 1 19 5.3
Bone fractures 5 143 3.5 0 19 0.0
Gastrointestinal distension 3 139 2.2 0 19 0.0
Aspiration pneumonia 2 128 1.6 2 18 11.1
Renal failure 2 131 1.5 0 19 0.0
#, variable statistically different between groups
Table 9: Severity grades of adult horses and foals with tetanus
Adult horses (155) Foals (22)
N n % N n %
Mild 35 155 22.6 6 21 28.6
Moderate 70 155 45.2 4 21 19.0 #
Severe 47 155 30.3 8 21 38.1
Very severe 3 155 1.9 3 21 14.3 #
Explanation of the severity grades can be found in Table 1.
#Variable statistically different between groups.
N, number of horses with a positive response; n, number of horses with a
response for this specific parameter.
current study. Comparatively, a larger number of other
complications were reported in the present study, which
can be explained by the increased accessibility to labo-
ratory facilities for monitoring blood analyses, and the
study design where reporting veterinarians were specif-
ically questioned on complications. Most common com-
plications or clinical signs that developed during hospi-
talization in the present studywere dysphagia, dyspnea,
recumbency, hyperthermia, seizures, hyperlipemia, gas-
trointestinal impactions, dysuria, and laryngeal spasms.
In addition to reporting on tetanus in adult horses,
the present study also describes the features of the dis-
ease in a group of foals. Differences were recognized be-
tween the groups with reference to the months of occur-
rence, signalment, management-related data, potential
causative events, clinical signs on admission, blood anal-
ysis, complications, and severity grades. Therefore, we
suggest that similar to the situation in human medicine,
tetanus in foals and tetanus in adult horses should be
considered as distinct syndromes. However, there was
no observable difference between groups for survival
rate and disease intervals.
This study indicates that cases of tetanus are uncom-
mon in most Western, Northern, and Central European
referral clinics, except for the University of Ghent and
of Liege, both located in Belgium. The number of cases
per country in this study is certainly an underestima-
tion of the true number of cases. Although this study
was not designed to study the incidence of tetanus, it
does suggest that case numbers seem relatively stable
over the last 15 years. It is reasonable to expect that
most foals would be affected from April to Septem-
ber, but it is unclear why a peak in adult cases occurs
in April and December. The case numbers also suggest
some differences between countries. The large difference
in case numbers between Belgium and the other Euro-
pean countries theoretically could either be due to lower
rates of immunization, or different degrees of exposure
of horses to Clostridium tetani through diversity of soil
contamination. Clostridium tetani is believed to be com-
monly present in the soil, but geographical differences
have been observed; for example, total absence of this
bacterium has been identified in the soils of the Rocky
Mountains and the Andes Mountains.1 Moreover, out-
breaks of tetanus have been reported following events
that result in significant environmental soil contamina-
tion, such as following earthquakes and tsunamis.21–23
It is unclear whether the vaccinated horses that devel-
oped tetanus in this study did so as a result of expo-
sure to a particularly high infectionpressure. They could,
however, be a consequence of lower immunization rates.
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In Belgium, the annual American Association of Equine
Practitioners vaccination scheme17 is routinely used, so
increased tetanus case numbers cannot be attributed to
vaccination schemeswith longer booster intervals. Other
reasonswhy vaccinated horses could develop tetanus in-
clude: poor immune response of the horse to the vaccine,
the owner not admitting that the horse was inappropri-
ately vaccinated, vaccination with an inappropriate ad-
ministration of the vaccine or an inappropriately stored
vaccine.
Only a small number of wounds in the horses af-
fected by tetanus in this studywere assessed for bacterial
contamination or the presence of Clostridium tetani. Al-
though the organism cannot be recovered in 46–70% of
human cases with anaerobic culturemethods,1,24 a Gram
stain can aid in identification of C tetani 1,25 Attempts to
culture C tetani from possible entry wounds can help to
confirm the diagnosis of tetanus, which is currently in
most equine cases restricted to identification of the typi-
cal clinical signs. Furthermore, knowledge on the bacte-
rial flora and antimicrobial susceptibility patterns of in-
fected entry wounds can be helpful to optimize wound
treatments. In two thirds of the described cases, no po-
tential entry site was detected.Clostridium tetani requires
anaerobic conditions in order to multiply and produce
its toxin, so it is likely that entry wounds are frequently
small stab wounds that rapidly heal. Consequently, they
can be easily missed under the hair coat. One result
of particular note was the observation that castration
and hoof abscesses were the most common predispos-
ing events for the development of tetanus in this group
of horses; this highlights the importance of undertaking
appropriate vaccination prior to performing elective sur-
gical procedures and TAT or booster vaccination in case
of hoof abscesses. Clostridium tetani is also a common in-
habitant of the gastrointestinal tract of horses 26 and, sim-
ilar to the situation in people, intestinal lesions are likely
to be a potential entry site for the bacterium in horses.27,28
Unfortunately in the present study insufficient datawere
gathered on deworming protocols and parasitic lesions
on postmortem examinations to study a possible relation
between parasitic infestations and the development of
tetanus.
Limitations of this study include its retrospective na-
ture and the large number of reporting clinicians. How-
ever, potential bias was limited by the use of standard-
ized data collection sheets, and the high response rate
for most variables in this study.
In conclusion, this study provides a current review of
the clinical features of a large number of tetanus cases,
both in adult horses and foals in Western and Central
Europe. The results provide clinicians with important
information about the history, early clinical signs, lab-
oratory results, clinical progression, and complications
of the disease. This information should aid clinicians to
achieve early diagnosis and provide good case manage-
ment of this uncommon, yet serious condition affecting
multiple organ systems, and requiring broad supportive
and intensive care. Neonatal and adult tetanus in the
horse should be considered as distinct syndromes, as in
human medicine.
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